Please assess the completion status of the following clinical trial:

Trial Title: Exercise Training Effects on Metabolic Syndrome: Interactions With Medication

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SEQUENTIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: EARLY_PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Metabolic syndrome patients diagnosed according to the International diabetes federation consensus of 2009 (Alberti, et al., Circulation).~* 18-65 years old~Exclusion Criteria:~Cardiovascular disease or musculo-skeletal that prevents them from being able to perform intense exercise.~* Respiratory failure~* Patient ends~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- PLACEBO FIRST THEN MEDICATED (Type: EXPERIMENTAL): Subjects first receive the PLACEBO tablet during 72 hours (full withdrawal). After a week of taking again their medication (MEDICATION TRIAL), they will be tested again. This procedure will be repeated before and after 4 months of aerobic training.
- MEDICATED FIRST THEN PLACEBO (Type: EXPERIMENTAL): Subjects first receive their antihypertensive MEDICATION tablet (habitual dose prescribed by their primary care doctors). After a week they will take a PLACEBO tablet for 72 hours and will be tested again. This procedure will be repeated before and after 4 months of aerobic training.

Based on this trial design, predict the completion outcome and termination type (if applicable).